BiVictriX Therapeutics Plc is a biotechnology company, which engages in the research and experimental development of pharmaceutical products. The firm also focuses on generating a pioneering new class of next-generation anti-cancer therapeutics which exhibit superior selectivity towards the cancer. The company was founded by Peter Jackson and Tiffany Thorn in 2016 and is headquartered in Cheshire, the United Kingdom.